These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 33260629)

  • 1. Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Luque-Tévar M; Collantes-Estevez E; Escudero-Contreras A; Pérez-Sánchez C
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies.
    Mueller AL; Payandeh Z; Mohammadkhani N; Mubarak SMH; Zakeri A; Alagheband Bahrami A; Brockmueller A; Shakibaei M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis.
    Maciejewska Rodrigues H; Jüngel A; Gay RE; Gay S
    Mol Immunol; 2009 Nov; 47(1):12-8. PubMed ID: 19232437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics.
    Conti V; Corbi G; Costantino M; De Bellis E; Manzo V; Sellitto C; Stefanelli B; Colucci F; Filippelli A
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33327600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA.
    Baxter D; McInnes IB; Kurowska-Stolarska M
    Immunol Cell Biol; 2012 Mar; 90(3):288-92. PubMed ID: 22249200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of exosome in autoimmunity, with a particular emphasis on rheumatoid arthritis.
    Hejrati A; Hasani B; Esmaili M; Bashash D; Tavakolinia N; Zafari P
    Int J Rheum Dis; 2021 Feb; 24(2):159-169. PubMed ID: 33159418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety implications of molecular constructs of biological agents for rheumatoid arthritis.
    Timlin H; Bingham CO
    Expert Opin Biol Ther; 2014 Jul; 14(7):893-904. PubMed ID: 24720727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.
    García-Hernández MH; González-Amaro R; Portales-Pérez DP
    Immunotherapy; 2014; 6(5):623-36. PubMed ID: 24896630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis.
    Zhao J; Jiang P; Guo S; Schrodi SJ; He D
    Front Immunol; 2021; 12():809806. PubMed ID: 35003139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenic Mechanisms and Novel Immune-Modulated Therapies in Rheumatoid Arthritis.
    Chen SJ; Lin GJ; Chen JW; Wang KC; Tien CH; Hu CF; Chang CN; Hsu WF; Fan HC; Sytwu HK
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One year in review 2018: pathogenesis of rheumatoid arthritis.
    Calabresi E; Petrelli F; Bonifacio AF; Puxeddu I; Alunno A
    Clin Exp Rheumatol; 2018; 36(2):175-184. PubMed ID: 29716677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunologic homunculus in rheumatoid arthritis. A new viewpoint of immunopathogenesis in rheumatoid arthritis and therapeutic consequences].
    Bläss S; Engel JM; Burmester GR
    Z Rheumatol; 2001 Feb; 60(1):1-16. PubMed ID: 11263010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis.
    Lin YJ; Anzaghe M; Schülke S
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year in review 2016: pathogenesis of rheumatoid arthritis.
    Bellucci E; Terenzi R; La Paglia GM; Gentileschi S; Tripoli A; Tani C; Alunno A
    Clin Exp Rheumatol; 2016; 34(5):793-801. PubMed ID: 27716458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From genetics to functional insights into rheumatoid arthritis.
    Suzuki A; Yamamoto K
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S40-3. PubMed ID: 26457422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-Regulated Key Components of Cytokine Signaling Pathways and Inflammation in Rheumatoid Arthritis.
    Sharma AR; Sharma G; Lee SS; Chakraborty C
    Med Res Rev; 2016 May; 36(3):425-39. PubMed ID: 26786912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.
    Koike T
    J Orthop Sci; 2015 Nov; 20(6):951-7. PubMed ID: 26404390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis.
    Holmdahl R; Malmström V; Burkhardt H
    Eur J Immunol; 2014 Jun; 44(6):1593-9. PubMed ID: 24737176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-22 and rheumatoid arthritis: emerging role in pathogenesis and therapy.
    Xie Q; Huang C; Li J
    Autoimmunity; 2015 Mar; 48(2):69-72. PubMed ID: 25483133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy.
    Filková M; Jüngel A; Gay RE; Gay S
    BioDrugs; 2012 Jun; 26(3):131-41. PubMed ID: 22494429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.